We value your privacy
Any information you provide to the National Glaucoma Society (NGS) is strictly confidential and maintained off-line. NGS will not transfer any of this information, including your name, address, e-mail address or telephone numbers, to any third party.
Upcoming Programs
December 2, 2020
Dr. Brian Mathie presents "Cannibis and the Eye" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, December 2.December 9, 2020
Dr. Nate Lighthizer presents "OCT-A" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, December 9.January 13, 2021
Dr. Mark Dunbar presents "Hot Topics in Retina" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, January 13.January 27, 2021
Dr. Jim Thimons and Dr. Joseph Panarelli present "Surgical Advances in Glaucoma Therapy" as a live webinar from 8:00-9:00 P.M. Eastern Time (7:00-8:00 PM. Central Time) on Wednesday, January 27.Your Registrations
You have no registrations currently in your cart.
News
CALIFORNIA ALLOWS LIVE WEBINARS AS LIVE CE
The California Board of Optometry now recognizes interactive courses offered live over internet platforms such as WebEx as Live CE toward the 30 hours of live continuing education required for license renewal. Courses can be live COPE courses offered by COPE's June 30, 2021 deadline or courses approved by the Board.COPE EXTENDS RULES ON INTERACTIVE WEBINARS
Interactive webinars offered through June 30, 2021 will be classified as Live COPE Events. These webinars will not require a test. The NGS live webinars through June 2021 will be submitted to COPE for approval as Live COPE Events. Thus, the webinars will meet the criteria for CE in most states. States may consider these webinars as live or on-line CE. More information is included in the description of the webinars on the NGS website. Some State Boards are modifying restrictions for on-line CE because of COVID-19. Check the website of your State Board of Optometry for the latest rulings.NEW FEATURE ON REGISTRATION PAGE
We have modified the registration page on the NGS website to eliminate duplicate registrations. If you try to register for a webinar for which you have already registered, the message "Already Registered" will appear on the page so you cannot add it to your cart. This should save time so that you do not go through the steps of registering again.SEPTEMBER - DECEMBER WEBINARS APPROVED IN TEXAS
The NGS webinars in September through December have been approved by the Texas Board of Optometry as live CE. This includes the one-hour Wednesday webinars as well as the National Glaucoma Symposium East on September 12-13 and the National Glaucoma Symposium West on October 11.MALVERN, PA PROGRAM CANCELLED FOR 2020
The National Glaucoma Society Regional Program Iin Malvern, PA will not be held in 2020, due to the restrictions on large groups and requirements for social distancing that we believe will continue through the fall because of the COVID-19 pandemic. Since both NJ and PA are allowing on-line CE during this renewal cycle, we invite you to participate in the NGS live webinars for your CE credit.NGS 1-HOUR WEBINARS
The NGS will offer two webinars per month in September-December and January - May. These webinars are included in Full NGS Membership.MA BOARD WAIVES LIMITS ON DISTANCE LEARNING
At its March 25 meeting, the Massachusetts Board of Optometry voted to waive the 6-hour limit on distance learning CE. For CE completed between January 1 and December 31, 2020, Massachusetts optometrists can obtain up to 18 hours of distance learning CE, provided the course is COPE approved, separately approved by the Board of Optometry, or offered by an organization specified in Massachusetts regulations as an approved entity. This policy will be posted to the Board's website soon, but is now in effect.NGS LIVE WEBINARS = CATEGORY 1 ABO
We have received confirmation that the NGS live webinars now count as Category 1 Education towards American Board of Optometry (ABO) certification.Join Our Email List
